1. Home
  2. AVA vs FOLD Comparison

AVA vs FOLD Comparison

Compare AVA & FOLD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Avista Corporation

AVA

Avista Corporation

HOLD

Current Price

$39.16

Market Cap

3.2B

Sector

Utilities

ML Signal

HOLD

Logo Amicus Therapeutics Inc.

FOLD

Amicus Therapeutics Inc.

HOLD

Current Price

$14.28

Market Cap

4.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AVA
FOLD
Founded
1889
2002
Country
United States
United States
Employees
N/A
N/A
Industry
Power Generation
Biotechnology: Pharmaceutical Preparations
Sector
Utilities
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.2B
4.4B
IPO Year
N/A
2007

Fundamental Metrics

Financial Performance
Metric
AVA
FOLD
Price
$39.16
$14.28
Analyst Decision
Hold
Buy
Analyst Count
2
9
Target Price
$39.50
$27.56
AVG Volume (30 Days)
801.1K
20.1M
Earning Date
02-25-2026
02-18-2026
Dividend Yield
5.03%
N/A
EPS Growth
N/A
N/A
EPS
2.35
N/A
Revenue
$1,964,000,000.00
$598,704,000.00
Revenue This Year
$1.44
$21.49
Revenue Next Year
N/A
$18.42
P/E Ratio
$16.58
N/A
Revenue Growth
2.14
21.28
52 Week Low
$34.80
$5.51
52 Week High
$43.09
$14.36

Technical Indicators

Market Signals
Indicator
AVA
FOLD
Relative Strength Index (RSI) 52.89 89.90
Support Level $38.08 $14.21
Resistance Level $38.82 $14.35
Average True Range (ATR) 0.51 0.08
MACD 0.11 -0.01
Stochastic Oscillator 73.80 97.72

Price Performance

Historical Comparison
AVA
FOLD

About AVA Avista Corporation

Avista Corp is an electric and natural gas utility company. The company has two business segments including Avista Utilities, which provides electric distribution and transmission, and natural gas distribution services in parts of eastern Washington and northern Idaho, and also provides natural gas distribution service in parts of northeastern and southwestern Oregon. Avista Utilities has electric generating facilities in Washington, Idaho, Oregon, and Montana. AEL&P is a regulated utility providing electric services in Juneau, Alaska that is a wholly-owned subsidiary and the primary operating subsidiary of AERC.

About FOLD Amicus Therapeutics Inc.

Amicus Therapeutics Inc is a patient-dedicated biotechnology company focused on discovering, developing and delivering novel high-quality medicines for people living with rare diseases. With extraordinary patient focus, the company is committed to advancing and expanding a pipeline of cutting-edge medicines for rare diseases. It has a portfolio of product opportunities, including oral precision medicine for people living with Fabry disease who have amenable genetic variants; a clinical-stage, treatment paradigm for Pompe disease, and a rare disease gene therapy portfolio. The company has one segment focused on the discovery, development, and commercialization of therapies to treat a range of devastating rare and orphan diseases.

Share on Social Networks: